Brief: Aptevo Therapeutics Reports Qtrly Loss Per Share Of $2.10
10/11/2020 23:25
Nov 10 (Reuters) - Aptevo Therapeutics Inc APVO.O :
* APTEVO THERAPEUTICS INC - QTRLY LOSS PER SHARE $2.10
* APTEVO THERAPEUTICS INC - FUNDING EXTENDS CASH RUNWAY INTO
2022
Source text: (https://bit.ly/35k5EFW)
Further company coverage: APVO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aptevo Therapeutics
See all newsBrief: Aptevo Therapeutics - Enters Amendment No. 6 To Rights Agreement On October 23, 2026 - SEC Filing
U.S. STOCKS ON THE MOVE-Principal Financial Group, NetApp
U.S. STOCKS ON THE MOVE-Genesco, Fervo Energy, Tyson Foods
Aptevo Therapeutics reports early data for blood cancer therapy; shares fall
Aptevo Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary